​

Funding Round

Series C - TetraLogic Pharmaceuticals

Series C - TetraLogic Pharmaceuticals

Investment Firm

Overview

TetraLogic Pharmaceuticals discovers and develops small molecule drugs for the treatment of debilitating diseases and conditions.

Announced Date

Jan 04, 2011

Closed on Date

Jan 05, 2011

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Clarus Ventures

Clarus Ventures

Clarus Ventures is a early_stage_venture and late_stage_venture and private_equity firm.

Participant Investors

10

Investor Name
Participant InvestorThe Vertical Group
Participant InvestorHealthCare Ventures
Participant InvestorHatteras Venture Partners
Participant InvestorQuaker BioVentures
Participant InvestorNovitas Capital

Round Details and Background

TetraLogic Pharmaceuticals raised $23000000 on 2011-01-04 in Series C

TetraLogic Pharmaceuticals discovers and develops small molecule drugs for the treatment of debilitating diseases and conditions.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 24, 2011
Series C - TetraLogic Pharmaceuticals
1-6.0M
Jan 04, 2011
Series C - TetraLogic Pharmaceuticals
11-23.0M
Sep 27, 2010
Series C - TetraLogic Pharmaceuticals
2-5.0M
Aug 10, 2010
Series C - TetraLogic Pharmaceuticals
8-32.0M

Recent Activity

There is no recent news or activity for this profile.